Manuela Bomba
Selected publications
- Bomba M, Granzotto A, Castelli V, et al. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer’s Disease. J Alzheimers Dis. 2019;70(3):793-810. doi:10.3233/JAD-190237
- Bomba M, Granzotto A, Castelli V, et al. Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice. Neurobiol Aging. 2018;64:33-43. doi:10.1016/j.neurobiolaging.2017.12.009
- Bomba M, Ciavardelli D, Silvestri E, et al. Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals. Cell Death Dis. 2013;4:e612. doi:10.1038/cddis.2013.139
- Frazzini V, Guarnieri S, Bomba M, et al. Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer’s disease mouse model. Cell Death Dis. 2016;7(2). doi:10.1038/cddis.2016.18
- Isopi E, Granzotto A, Corona C, et al. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer’s disease without reducing amyloid and tau pathology. Neurobiol Dis. 2015;81:214-224. doi:10.1016/j.nbd.2014.11.013